ArticleCancer immunology, immunotherapy : CII2023

Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study.

Kenji Sawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.